{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T22:38:33Z","timestamp":1648852713502},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[1995]]},"DOI":"10.2165\/00003495-199500501-00004","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T11:02:43Z","timestamp":1196852563000},"page":"15-25","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic Markers in Rheumatoid Arthritis and Classification of Antirheumatic Therapies"],"prefix":"10.1007","volume":"50","author":[{"given":"Ernest H.S.","family":"Choy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Drugs"],"original-title":[],"language":"en","deposited":{"date-parts":[[2013,1,20]],"date-time":"2013-01-20T14:40:58Z","timestamp":1358692858000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00003495-199500501-00004"}},"subtitle":["New Perspectives"],"short-title":[],"issued":{"date-parts":[[1995]]},"references-count":0,"journal-issue":{"issue":"Supplement 1"},"URL":"https:\/\/doi.org\/10.2165\/00003495-199500501-00004","relation":{},"ISSN":["0012-6667"],"issn-type":[{"value":"0012-6667","type":"print"}],"subject":[],"published":{"date-parts":[[1995]]}}}